Seminars in Oncology

Papers
(The median citation count of Seminars in Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Clinical efficacy and security analysis of DEB-TACE combined with trans arterial infusion of carrelizumab in the therapy of advanced liver cancer56
Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer53
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis31
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review30
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance24
Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment20
Overexpression of CAD in stomach adenocarcinoma tissues and its clinical significance20
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics18
Table of Contents18
Pretreatment eosinophilia as a biomarker for adverse outcomes in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis18
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer18
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations17
Psoas muscle depletion correlates with poor prognosis and compromised immunity in resectable gastric cancer: A multicenter study17
Editorial Board16
Role of neoadjuvant pembrolizumab in advanced melanoma13
Military exposures and lung cancer in United States Veterans13
Editorial Board13
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans13
Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy response11
Adenocarcinoma on retrorectal cystic hamartoma: An illustrative image for a very rare diagnosis11
Editorial Board10
Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC)10
Assessment of PSA responses and changes in the rate of tumor growth -rate with immune checkpoint inhibitors in US Veterans with prostate cancer10
Masthead10
Masthead10
The interest of therapeutic and pharmacological drug monitoring of methotrexate: A systematic review10
Acute liver failure secondary to malignant infiltration: A single center experience10
Surgery for early-stage lung cancer with video-assisted thoracoscopic surgery versus open thoracotomy: A narrative review9
The knowns and unknowns of disparities, biology, and clinical outcomes in Hispanic and Latinx multiple myeloma patients in the U.S.9
Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper use9
Hexokinases in gastrointestinal cancers: From molecular insights to therapeutic opportunities9
Breast cancer exosomes: Managing macrophage polarization and immune regulation in the tumor microenvironment9
Masthead9
The effects of microbiota-derived short-chain fatty acids on T lymphocytes: From autoimmune diseases to cancer9
Lactylation in radiosensitivity regulation: Mechanistic insights and recent advances9
Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer8
Editorial Board8
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population8
Mapping the epidemiology of cancer-related anemia: A systematic scoping review of global prevalence and incidence8
The challenges of selecting cancer medicines for the WHO Essential Medicines List with the elephant in the room: A path forward8
Barriers and facilitators to lung cancer screening and follow-up8
Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing—The experience of a large oncology center in t7
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects7
Screening Adherence for Second Primary Malignancies in Breast Cancer Survivors: Behaviors, Facilitators, and Barriers to Enhance Quality Care7
Recent updates on novel heterocyclic scaffolds of anticancer potential as emerging tubulin inhibitors7
MicroRNAs: From Bench to Bedside Applications as Breast Cancer Therapeutics6
Current and prospective antibody-based therapies in multiple myeloma6
Masthead6
Multiple myeloma: Insights into underlying mechanisms, advances in diagnostic and therapeutic modalities6
A narrative review of the principal glucocorticoids employed in cancer6
High tumor mutation burden mitigates the negative impact of chemotherapy history on immune checkpoint blockade therapy5
Radiation recall dermatitis: A review of the literature5
Colorectal cancer in Ethiopia: Epidemiological trends, diagnostic and laboratory capacities, and challenges5
Editorial Board5
Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer5
Exosomal circular RNAs as drivers of temozolomide resistance in glioblastoma: Mechanisms and implications5
outside front cover5
Advances and challenges in cancer immunotherapy: Strategies for personalized treatment5
Unveiling the role of RAI14 in cancer: Biological significance and translational perspectives4
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data4
Masthead4
Editorial Board4
Are we there yet? Gut microbiota for cancer diagnosis, prognosis and treatment4
Treating advanced lung cancer in older Veterans with comorbid conditions and frailty4
Masthead4
Daratumumab: A review of current indications and future directions4
TOC3
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review3
Outcomes with panobinostat in heavily pretreated multiple myeloma patients3
Baicalein and baicalin in cancer therapy: Multifaceted mechanisms, preclinical evidence, and translational challenges3
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety3
Table of Contents3
Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis3
Outside front cover3
Masthead3
Metabolism at the core of melanoma: From bioenergetics to immune escape and beyond3
Table of Contents3
PARP inhibitors in ovarian cancer3
Assessing Outcomes in NSCLC: Radiomic analysis, kinetic analysis and circulating tumor DNA3
Table of Contents3
Outside front cover3
Comorbidity and life expectancy in shared decision making for lung cancer screening3
Prostate cancer in Türkiye: Trend analysis of incidence and mortality rates3
outside front cover3
The impact of the COVID-19 pandemic on tertiary care cancer center: Analyzing administrative data3
Fingerprint change as a consequence of anticancer treatments: A systematic integrative review2
Scoping to analyze oncology trial participation in Australia2
Non-small cell lung cancer in the era of immunotherapy2
Masthead2
The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics2
outside front cover2
The dual effect of interferon-γ in acute myeloid leukemia: A narrative review2
Divergent functions of TLRs in gastrointestinal (GI) cancer: Overview of their diagnostic, prognostic and therapeutic value2
Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias2
TOC2
Editorial Board2
The Crucial Nexus: Unveiling the Role of Collagen in Cancer Progression2
Which future for de-intensified treatments in HPV-related oropharyngeal carcinoma?2
TOC2
Table of Contents2
Examining health related quality of life outcomes in multiple myeloma: Past and future perspectives2
Epidemiology and genetics of early onset colorectal cancer—African overview with a focus on Ethiopia2
Editorial Board2
Editorial Board2
Current perspectives, guiding lights to the future, and transforming care for patients with multiple myeloma2
Lung cancer screening at the VA: Past, present and future2
Outside front cover1
TOC1
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis1
Deciphering the prognostic value and immunotherapeutic strategy of aggrephagy in melanoma: Integrating single-cell sequencing and machine learning1
Epidemiology and prevention of gastric cancer: A comprehensive review1
Lung Cancer Screening and Precision Oncology1
Artificial intelligence in Gynaecologic Oncology: A cautionary look in the Indian context1
Deciphering autophagy signaling in cancer: A paradigm shift from molecular classifications to clinical innovations1
Lung cancer: Premalignant biology and medical prevention1
TOC1
Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer1
Table of Contents1
TOC1
Table of Contents1
Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents1
Overcoming barriers to opioid-induced constipation management in cancer patients1
Masthead1
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management1
Deregulated cell cycle control: The interplay between non-coding RNAs and cyclin-dependent kinases in tumorigenesis1
Liquid biopsy: An innovative tool in oncology. Where do we stand?1
0.054452896118164